{"id":"https://openalex.org/W7212066673","doi":"https://doi.org/10.1016/j.neurot.2026.e00984","title":"Phase 3 EPIC (EPIlepsy Cell Therapy) Clinical Trial Design: NRTX-1001 GABAergic Interneuron Cell Therapy for the Treatment of Drug-Resistant Mesial Temporal Lobe Epilepsy (MTLE)","display_name":"Phase 3 EPIC (EPIlepsy Cell Therapy) Clinical Trial Design: NRTX-1001 GABAergic Interneuron Cell Therapy for the Treatment of Drug-Resistant Mesial Temporal Lobe Epilepsy (MTLE)","publication_year":2026,"publication_date":"2026-07-01","ids":{"openalex":"https://openalex.org/W7212066673","doi":"https://doi.org/10.1016/j.neurot.2026.e00984"},"language":"en","primary_location":{"id":"doi:10.1016/j.neurot.2026.e00984","doi":"https://doi.org/10.1016/j.neurot.2026.e00984","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.neurot.2026.e00984","pdf_url":"https://www.neurotherapeuticsjournal.org/article/S1878-7479(26)00154-6/pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.neurotherapeuticsjournal.org/article/S1878-7479(26)00154-6/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5138303255","display_name":"John Hixson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Hixson","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093010888","display_name":"Gautam Banik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gautam Banik","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040709584","display_name":"Marina Bershteyn","orcid":"https://orcid.org/0009-0002-6611-9197","observed_orcids":["https://orcid.org/0009-0002-6611-9197"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina Bershteyn","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016966812","display_name":"Alessandro Bulfone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alessandro Bulfone","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091195148","display_name":"Brianna G Feld","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brianna Feld","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046419533","display_name":"Luis C. Fuentealba","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luis Fuentealba","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138389491","display_name":"Stephanie Hughes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephanie Hughes","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5150968748","display_name":"Ji-Hye Jung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ji-Hye Jung","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061355642","display_name":"Tia J. Kowal","orcid":"https://orcid.org/0000-0003-3879-4718","observed_orcids":["https://orcid.org/0000-0003-3879-4718"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tia Kowal","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051660914","display_name":"Sonja Kriks","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sonja Kriks","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010499792","display_name":"Rose Larios","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rose Larios","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112230202","display_name":"Ng\u1ecdc Minh L\u00ea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ngoc Minh Le","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029120632","display_name":"Seonok Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seonok Lee","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109466298","display_name":"Sheri Madrid","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sheri Madrid","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016075172","display_name":"Yves Maury","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yves Maury","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138307804","display_name":"Catherine Priest","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine Priest","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028161132","display_name":"Cory R. Nicholas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cory Nicholas","raw_affiliation_strings":["Neurona Therapeutics, S San Francisco, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurona Therapeutics, S San Francisco, CA, United States of America","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":{"value":3900,"currency":"USD","value_usd":3900},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.69591032,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"4","first_page":"e00984","last_page":"e00984"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Neurological disorders and treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cell-therapy","display_name":"cell therapy","score":0.7179999947547913},{"id":"https://openalex.org/keywords/drug-resistant-epilepsy","display_name":"drug-resistant epilepsy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/mesial-temporal-lobe-epilepsy","display_name":"mesial temporal lobe epilepsy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gabaergic-interneurons","display_name":"GABAergic interneurons","score":0.9850000143051147},{"id":"https://openalex.org/keywords/medial-ganglionic-eminence","display_name":"medial ganglionic eminence","score":0.996999979019165},{"id":"https://openalex.org/keywords/pluripotent-stem-cell-derived-neurons","display_name":"pluripotent stem cell-derived neurons","score":0.828000009059906},{"id":"https://openalex.org/keywords/seizure-foci","display_name":"seizure foci","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C2779177108","wikidata":"https://www.wikidata.org/wiki/Q18356742","display_name":"GABAergic","level":3,"score":0.6615999937057495},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.640999972820282},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.6032000184059143},{"id":"https://openalex.org/C2994116697","wikidata":"https://www.wikidata.org/wiki/Q616667","display_name":"Mesial temporal lobe epilepsy","level":4,"score":0.5781999826431274},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5139999985694885},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5045999884605408},{"id":"https://openalex.org/C16568411","wikidata":"https://www.wikidata.org/wiki/Q83042","display_name":"Neurology","level":2,"score":0.49320000410079956},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.48559999465942383},{"id":"https://openalex.org/C2781099131","wikidata":"https://www.wikidata.org/wiki/Q744385","display_name":"Temporal lobe","level":3,"score":0.47920000553131104},{"id":"https://openalex.org/C115519274","wikidata":"https://www.wikidata.org/wiki/Q267903","display_name":"EPIC","level":2,"score":0.4442000091075897},{"id":"https://openalex.org/C2992477034","wikidata":"https://www.wikidata.org/wiki/Q83042","display_name":"Clinical neurology","level":2,"score":0.3991999924182892},{"id":"https://openalex.org/C2779296341","wikidata":"https://www.wikidata.org/wiki/Q1500732","display_name":"Interneuron","level":3,"score":0.38580000400543213},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3370000123977661},{"id":"https://openalex.org/C2780803581","wikidata":"https://www.wikidata.org/wiki/Q1347108","display_name":"Epilepsy surgery","level":3,"score":0.3215000033378601},{"id":"https://openalex.org/C12770488","wikidata":"https://www.wikidata.org/wiki/Q188449","display_name":"Neurosurgery","level":2,"score":0.3149999976158142},{"id":"https://openalex.org/C2777172819","wikidata":"https://www.wikidata.org/wiki/Q240642","display_name":"Valproic Acid","level":3,"score":0.3109000027179718},{"id":"https://openalex.org/C2777876421","wikidata":"https://www.wikidata.org/wiki/Q1637174","display_name":"Lobe","level":2,"score":0.30820000171661377},{"id":"https://openalex.org/C2777803345","wikidata":"https://www.wikidata.org/wiki/Q7140388","display_name":"partial seizures","level":3,"score":0.30480000376701355},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.2865000069141388},{"id":"https://openalex.org/C2910833928","wikidata":"https://www.wikidata.org/wiki/Q18975053","display_name":"Drug Resistant Epilepsy","level":3,"score":0.2858999967575073},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.27630001306533813},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.2621999979019165},{"id":"https://openalex.org/C2779281540","wikidata":"https://www.wikidata.org/wiki/Q5062122","display_name":"Central nervous system disease","level":2,"score":0.2547000050544739}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.neurot.2026.e00984","doi":"https://doi.org/10.1016/j.neurot.2026.e00984","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.neurot.2026.e00984","pdf_url":"https://www.neurotherapeuticsjournal.org/article/S1878-7479(26)00154-6/pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:cd6d688e867249fa9dba813df43571d0","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/cd6d688e867249fa9dba813df43571d0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neurotherapeutics, Vol 23, Iss 4, Pp e00984- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.neurot.2026.e00984","doi":"https://doi.org/10.1016/j.neurot.2026.e00984","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.neurot.2026.e00984","pdf_url":"https://www.neurotherapeuticsjournal.org/article/S1878-7479(26)00154-6/pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Study Protocol","id":"https://openalex.org/study-designs/study-protocol"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7212066673.pdf","grobid_xml":"https://content.openalex.org/works/W7212066673.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7164158575","https://openalex.org/W7164154028","https://openalex.org/W7212051997","https://openalex.org/W4409237534","https://openalex.org/W4387377358","https://openalex.org/W4394599827","https://openalex.org/W4387364533","https://openalex.org/W4389368927","https://openalex.org/W4392884448","https://openalex.org/W7153231528"],"abstract_inverted_index":{"The":[0],"objective":[1],"is":[2],"to":[3,24],"present":[4],"the":[5,19,35,44],"Phase":[6],"3":[7],"EPIC":[8],"(EPIlepsy":[9],"Cell":[10],"Therapy)":[11],"trial":[12],"design":[13],"evaluating":[14],"NRTX-1001":[15],"cell":[16,56],"therapy":[17,57],"for":[18,42,66],"treatment":[20],"of":[21,46],"seizures":[22],"due":[23],"drug-resistant":[25],"mesial":[26],"temporal":[27],"lobe":[28],"epilepsy":[29],"(MTLE).":[30],"GABAergic":[31,54],"cortical":[32,47,52],"interneurons":[33],"from":[34,61],"medial":[36],"ganglionic":[37],"eminence":[38],"(MGE)":[39],"are":[40],"critical":[41],"regulating":[43],"excitability":[45],"circuits.":[48],"We":[49],"developed":[50],"a":[51],"MGE-type":[53],"interneuron":[55],"candidate,":[58],"NRTX-1001,":[59],"derived":[60],"human":[62],"pluripotent":[63],"stem":[64],"cells":[65],"single-dose":[67],"administration":[68],"into":[69],"seizure":[70],"foci.":[71]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2026-09-10T00:00:00"}